GLAND PHARMA LIMITED (GLAND)

NSE: ₹2,219.50
BSE: ₹2,220.90
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 884.07 1,010.67 1,097.86 1,174.83 1,012.02 1,062.99 1,010.78 1,030.35 1,038.84 1,074.15 1,177.51 1,261.59
YOY Revenue Growth % 3.17% -3.59% 18.57% 49.58% 14.47% 5.18% -7.93% -12.3% 2.65% 1.05% 16.5% 22.44%
Other Income 35.21 41.11 43.39 46.96 48.49 57.80 65.06 43.72 54.74 82.59 60.21 106.36
Total Income 919.28 1,051.78 1,141.25 1,221.79 1,060.51 1,120.79 1,075.85 1,074.07 1,093.58 1,156.74 1,237.72 1,367.95
Total Expenses + 665.29 704.72 769.50 789.10 760.20 740.98 681.72 682.75 731.19 748.07 800.92 803.15
Cost of Materials Consumed 391.80 456.63 378.43 482.88 367.69 399.87 348.91 469.39 439.82 459.59 434.85 460.96
Employee Benefit Expense 102.91 99.88 99.29 107.87 107.68 106.29 105.36 119.70 128.44 132.28 134.14 133.96
Other Expenses 146.70 123.67 140.57 117.46 132.27 122.63 137.69 111.32 125.07 147.38 157.46 135.13
Operating Profit 218.78 305.95 328.37 385.73 251.83 322.01 329.07 347.61 307.64 326.08 376.60 458.44
OPM % 24.7% 30.3% 29.9% 32.8% 24.9% 30.3% 32.6% 33.7% 29.6% 30.4% 32% 36.3%
Profit Before Tax + 253.99 347.06 371.76 432.69 300.32 379.82 394.13 391.32 362.38 408.67 412.46 564.80
Tax Expense 66.41 89.54 94.95 111.28 77.39 98.11 99.01 101.32 93.13 106.68 104.61 144.35
Tax % 26.1% 25.8% 25.5% 25.7% 25.8% 25.8% 25.1% 25.9% 25.7% 26.1% 25.4% 25.6%
Profit After Tax 187.58 257.53 276.81 321.41 222.92 281.71 295.12 290.00 269.26 302.00 307.85 420.45
EPS (Basic) 11.39 15.64 16.81 19.51 13.53 17.10 17.91 17.60 16.34 18.33 18.68 25.52

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 4,552.09 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88
YOY Revenue Growth % 10.59% -1.23% 15.23% -17.82% 27.08% -
Other Income 303.90 215.08 166.67 240.46 223.94 134.78
Total Income 4,855.99 4,331.22 4,334.09 3,856.99 4,624.65 3,597.65
Total Expenses + 3,083.33 2,865.64 2,928.60 2,752.13 3,005.61 2,262.80
Cost of Materials Consumed 1,795.22 1,585.86 1,709.74 1,716.75 2,046.86 1,749.16
Employee Benefit Expense 528.82 439.02 409.95 399.70 338.57 311.36
Other Expenses 565.04 503.91 528.39 512.85 442.29 357.38
Operating Profit 1,468.76 1,250.51 1,238.83 864.40 1,395.10 1,200.08
OPM % 32.3% 30.4% 29.7% 23.9% 31.7% 34.7%
Profit Before Exceptional 1,772.66 1,465.59 1,405.50 1,104.86 1,619.04 1,334.85
Exceptional Items -24.35 0.00 0.00 -56.46 0.00 0.00
Profit Before Tax + 1,748.31 1,465.59 1,405.50 1,048.40 1,619.04 1,334.85
Tax Expense 448.76 375.83 362.17 272.58 406.89 337.85
Tax % 25.7% 25.6% 25.8% 26% 25.1% 25.3%
Profit After Tax 1,299.55 1,089.75 1,043.33 775.83 1,212.16 997.01
EPS (Basic) 78.88 66.15 63.35 47.12 73.84 63.07

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 5,185.00 4,654.66 4,969.76 1,884.84 1,989.70 1,372.99
Property, Plant & Equipment 1,683.94 1,735.86 1,682.47 1,558.50 1,499.09 953.49
Capital Work in Progress 137.63 42.21 120.01 177.22 180.75 337.81
Non-Current Investments 3,292.55 2,789.57 2,385.74 8.16 8.16 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 1.99 6.46 11.05 11.66 2.54 0.00
Current Assets + 6,422.22 5,766.96 4,571.33 6,888.34 5,844.44 5,123.07
Inventories 1,265.20 1,254.23 1,260.21 1,945.30 1,185.67 1,275.17
Trade Receivables 1,520.69 1,142.90 1,171.40 862.84 1,198.78 670.97
Cash and Cash Equivalents 3,177.64 2,432.62 116.21 1,905.22 311.18 491.92
Current Investments 0.00 0.00 0.00 0.00 154.87 0.00
LIABILITIES & EQUITY
Total Equity 10,810.03 9,755.10 8,995.29 7,953.30 7,158.23 5,903.29
Equity Share Capital 16.48 16.48 16.47 16.47 16.43 16.36
Other Equity 10,793.56 9,738.63 8,978.82 7,936.83 7,141.80 5,886.93
Non-Current Liabilities 164.16 142.75 131.60 89.68 93.98 80.31
Current Liabilities 633.03 523.77 414.20 730.20 581.94 512.46
Total Liabilities 797.18 666.52 545.80 819.88 675.91 592.77

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 1,135.23 1,073.67 1,135.97 367.89 791.29 604.93
Cash from Investing Activities -95.56 1,578.20 -2,923.92 1,208.22 -1,010.23 -1,524.55
Cash from Financing Activities -316.18 -339.54 -7.40 14.92 34.90 1,238.46
Net Increase/Decrease in Cash 745.02 2,316.42 -1,789.01 1,594.04 -180.73 322.42